AusBiotech Shines a Spotlight on Queensland
Ahead of the AusBiotech International Conference 2026, a look at Queensland's biomedical sector, where emerging technologies stand and what industry needs now.
In 10 days, Queensland will open its doors for the AusBiotech International Conference 2026. Ahead of the week that attracts thousands of delegates from across the sector, we are unpacking what makes Queensland different, where emerging technologies stand and what the broader industry needs today.
A Booming Biomedical Hub
Queensland offers a well-integrated biomedical ecosystem that brings together clinical care, research, manufacturing and global industry partners, transforming ideas into outcomes.
The growing biotech and medtech sector employs more than 27,000 people across industry and research, while housing over 230 biomedical companies.
The state boasts an experienced clinical trial services network to undertake rigorous, high-quality trials across all phases and areas, generating globally accepted data. Health precincts connect tertiary hospitals, universities, research institutes and industry partners.
Queensland is stabilising its position as a leader in the development and delivery of next-generation healthcare by adopting emerging technologies.
Technologies that make a Difference
ARM Hub Chief Commercial Officer Samuel Jesuadian believes that companies across Australia are increasingly seeing the benefits of emerging technologies, moving from absolute caution to careful adoption.
Brisbane-based biotech start-up Microbio leveraged AI to support its rapid diagnostic test, while Perth-based Neurotechnology start-up Cortical Dynamics used synthetic datasets and AI to develop both technology that monitors the brain during surgery, and software that predicts how patients will recover afterwards.
The conversation around AI, Samuel notes, is maturing.
"We are moving away from the noise of AI to tangible benefits that translate to real-world applications, from the lab to the manufacturing floor."
What the Industry Needs
For Australia's biomedical sector to keep its momentum, government, research and industry need to keep backing it, so that the innovations built here stay here.
That is the gap ARM Hub was set up to close, turning that support into tangible outcomes for the sector.
"We are uniquely positioned at the intersection of government and industry, helping businesses scale while retaining their IP within Australia," said Samuel.
If data access is holding your team back, whether inside your business or with external stakeholders, come see us at the AusBiotech International Conference.
Register here: https://ausbiotechic.com/